Clinical Trial Update: RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes RK-4 intracalvariosseous injection being evaluated for acute large hemispheric infarction and acute ischemic stroke, curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Large Hemispheric Infarction
• Stroke

Drugs mentioned

• RK-4

Snippet

Sponsor: Neurodawn Pharmaceutical Co., Ltd. | Conditions: Transcranial Bone Marrow Injection, RK-4 | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING